In contrast, miR-16 acts as a tumor suppressor and can restore trastuzumab and lapatinib sensitivity by suppressing Cyclin J (CCNJ) and Far Upstream Element Binding Protein 1 (FUBP1) in resistant BC [105]. Here, FUBP1 is linked to neoplasm.